Physician profile
John Patrick Barrett
NPI 1104886688
$17,853.01
in general payments reported to CMS, 2019-2025
16 companies · $8,833 in 2025
The $8,833 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.10 · 2022: $151 · 2023: $278 · 2024: $8,527 · 2025: $8,833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $1,464 · Travel and Lodging: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,000.00 |
| Food and Beverage | $1,464.43 |
| Travel and Lodging | $172.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,043.19 | 2024-2025 | |
| Caldera Medical, INC | $200.28 | 2022-2023 | Desara |
| Baxter Healthcare | $168.04 | 2025 | Perclot |
| Abbvie INC. | $95.14 | 2019-2025 | Orilissa |
| Novo Nordisk INC | $80.61 | 2023-2024 | Wegovy |
| Pfizer INC. | $46.40 | 2019-2024 | |
| Coopersurgical, INC. | $41.67 | 2019-2022 | |
| Biogen, INC. | $25.44 | 2024 | |
| Sumitomo Pharma America, INC. | $24.59 | 2023 | Myfembree |
| Pacira Pharmaceuticals Incorporated | $23.10 | 2022 | |
| Daiichi Sankyo INC. | $21.81 | 2023 | Injectafer |
| Solventum Corporation | $20.18 | 2024 | Activ.A.C. |
| Boston Scientific Corporation | $19.18 | 2023 | |
| Astellas Pharma US INC | $18.19 | 2024 | Veozah |
| Channel Medsystems, INC. | $14.81 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $10.38 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.